Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19
May 16, 2022 updated by: Centre Hospitalier Universitaire de Nice
Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19 in the Alpes-Maritimes and the City of Nice
Socio-demographic factors in relation to the diagnosis of COVID cases are increasingly mentioned in the role of transmission, but unfortunately with a small number of conclusive publications on French data.
Our objective is to analyse the distribution of cases according to these factors and their possible role during the first 6 weeks of 2021 when the Alpes Maritimes was the department with the highest incidence rate.
The collaboration between ARS06 and the Public Health Department in the field of COVID-19 has made it possible to have a departmental bulletin for monitoring the evolution of the epidemic (incidence, screening, hospitalisation).
Knowledge of the socio-demographic, meteorological and environmental factors associated with the transmission of SARS-CoV2 would make it possible to reflect on how to act on these factors and to implement a public health policy.
Study Overview
Study Type
Observational
Enrollment (Actual)
28377
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nice, France, 06001
- CHU de Nice
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 120 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Population of legal age or not residing in the Alpes Maritimes department between 03/01/2021 and 14/02/2021, i.e. 1078729 inhabitants in the Alpes Maritimes, including 342979 in the city of Nice
Description
Inclusion Criteria:
Any person, adult or not, residing in the Alpes-Maritimes between 03/01/2021 and 14/02/2021 with a COVID-19 diagnosis.
Exclusion Criteria:
Non resident in the Alpes-Maritimes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period.
Time Frame: Between 03/01/2021 and 14/02/2021
|
Weekly incidence rate in the Alpes Maritimes according to the age group, by district of Nice and town
|
Between 03/01/2021 and 14/02/2021
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to participants' social and economic factors
Time Frame: Between 03/01/2021 and 14/02/2021
|
Weekly incidence rate by social disadvantage index and others socioeconomic indicators by Census block of Nice, correlation analyses
|
Between 03/01/2021 and 14/02/2021
|
|
Weekly incidence rate of COVID-19 in the Alpes-Maritimes during the study period according to climatic factors
Time Frame: Between 03/01/2021 and 14/02/2021
|
Correlation of incidence rates with temperature, humidity, concentrations in air pollutants (fine particles, nitrogen oxides)
|
Between 03/01/2021 and 14/02/2021
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2021
Primary Completion (Actual)
February 14, 2021
Study Completion (Actual)
February 14, 2021
Study Registration Dates
First Submitted
May 16, 2022
First Submitted That Met QC Criteria
May 16, 2022
First Posted (Actual)
May 18, 2022
Study Record Updates
Last Update Posted (Actual)
May 18, 2022
Last Update Submitted That Met QC Criteria
May 16, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22DSP01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.